Integrated care improves chronic metrics

Putting mental-health treatment inside a primary-care visit can improve diabetes and blood-pressure control, not just depression scores. (pmc.ncbi.nlm.nih.gov) The idea is simple: a primary-care clinic adds a behavioral-health clinician or care manager, tracks patients between visits, and adjusts treatment for depression and chronic disease together instead of in separate silos. A 2025 systematic review of 64 studies found these models produced modest but significant drops in glycated hemoglobin, or HbA1c, and often improved adherence and self-management. (pmc.ncbi.nlm.nih.gov) HbA1c is a three-month average of blood sugar, so a lower number usually means better diabetes control. In the 2022 meta-analysis of collaborative care for people with diabetes and depression, the pooled reduction in HbA1c versus usual care was 0.33 percentage points. (pmc.ncbi.nlm.nih.gov) That effect has shown up in individual trials too. A 2025 pragmatic trial in eight community health centers in China enrolled 630 adults with type 2 diabetes and depression and found the integrated-care group was 19.16 percentage points more likely to achieve at least a 0.5-point HbA1c reduction at 12 months. (diabetesjournals.org) Blood-pressure gains have also appeared when clinics manage mental and physical conditions together. In the INDEPENDENT randomized trial, JAMA defined cardiometabolic improvement as including at least a 5-millimeter-of-mercury drop in systolic blood pressure, and TEAMcare tracked blood pressure alongside depression and glucose in primary care patients with multiple chronic conditions. (jamanetwork.com) (annfammed.org) The mechanism is less about one therapy session than about follow-up. In TEAMcare, run in 14 primary-care clinics from 2007 to 2009 with 214 patients, nurse care managers worked with physicians and consultants to intensify treatment across depression, diabetes, and heart disease targets. (annfammed.org) That trial found antidepressant starts or adjustments were six times higher in the intervention group, insulin changes were about three times higher, and antihypertensive medication adjustments were nearly twice as high. Patients in the program also checked blood pressure more often and monitored glucose more frequently. (annfammed.org) The adherence picture is more mixed than some promotional posts suggest. The 2025 diabetes-and-mental-health review said many interventions improved adherence and self-management, and the 2025 China trial reported higher medication-adherence scores, but TEAMcare found no difference in medication adherence at 12 months, partly because baseline adherence was already high. (pmc.ncbi.nlm.nih.gov) (diabetesjournals.org) (annfammed.org) Primary-care groups have been trying to move this model from trials into routine practice. Aledade says it works with more than 3,000 primary-care partners and uses data tools to identify at-risk patients and close care gaps, while Taria Health says it focuses on follow-up between visits for people managing diabetes and hypertension. (aledade.com) (tariahealth.com) The push comes as access to behavioral-health care remains thin in the United States. A 2022 Robert Graham Center report said 15% to 20% of U.S. adults report ever being diagnosed with depression or mental illness, while fewer than half of people with a mental illness reported receiving care in the past year. (graham-center.org) The evidence base is now broad enough that the University of Washington’s AIMS Center says collaborative care has been tested in more than 90 randomized controlled trials. The harder part is turning that research model into a standard primary-care workflow that keeps patients engaged after they leave the exam room. (aims.uw.edu)